Continue Reading
Full article on Financial Times
Moderna is most shorted stock in S&P 500 as Americans skip jabs
Market Intelligence Analysis
AI-Powered
Why This Matters
Moderna, the COVID-19 vaccine manufacturer, has become the most shorted stock in the S&P 500 as Americans' sentiment towards vaccines has shifted, leading to a decline in the company's stock price since the pandemic.
Market Impact
Market impact analysis based on bearish sentiment with 82% confidence.
Sentiment
Bearish
AI Confidence
82%
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
Maker of Covid-19 shots has slumped since pandemic as people turn against vaccines
Original article published by
Financial Times
on November 23, 2025.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.